BabyGen is a molecular test
to determine the sex of the foetus
Unique
It can analyse the widest range of fetal chromosomal disorders across the entire genome from as early as 11. week of pregnancy.
Reliable
More than 99.5% accuracy
Comprehensive
It provides detailed fetal DNA screening and free verification of a positive result by amniotic fluid testing with the GenomeScreen prenatal test.
Painless
Examination of the mother’s blood.
Quick
Result available from week 10.
Secure
No risk to the fetus.
Answers hidden in the blood
BabyGen is a non-invasive genetic screening test for fetal sex, which is performed in a genetic laboratory by analysing a sample of the mother’s blood, from as early as 10. week of pregnancy. Sensitive molecular methods based on DNA analysis can identify the presence of the Y chromosome in the blood of a pregnant woman. It is currently the most accurate prenatal test of fetal sex, determining the result with more than 99.5% accuracy.*
* The result is validated on more than 1500 retrospectively and prospectively analysed samples of pregnant women.
Knowing the sex of your baby before birth is not only something future parents want to do out of curiosity, but also if the sex of the baby matters from a health point of view. This may be due, for example, to the presence of a hereditary disease that is sex-linked. The most common examples are haemophilia and Duchenne muscular dystrophy, which is the most severe form of muscular dystrophy ever.
Thus, in the case of clinically indicated sex determination, the mother-to-be does not necessarily have to undergo an invasive procedure in which the doctor takes amniotic fluid samples directly from the uterus.
TRISOMY Test
The sex of the fetus is also detected by the prenatal TRISOMY test, which can also reliably rule out common fetal chromosomal disorders such as Down syndrome.
More about the TRISOMY test